Economic model for emergency use authorization of intravenous peramivir.

The American journal of managed care

Volumn 17, Issue 1, 2011, Pages

  Lee, Bruce Y ^a   Tai, Julie H Y ^b   Bailey, Rachel R ^b   McGlone, Sarah M ^b   Wiringa, Ann E ^b   Zimmer, Shanta M ^b   Smith, Kenneth J ^b   Zimmerman, Richard K ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOPENTANE DERIVATIVE; GUANIDINE DERIVATIVE; PERAMIVIR;

ADULT; ARTICLE; COMPARATIVE STUDY; COMPUTER SIMULATION; CONFIDENCE INTERVAL; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MONTE CARLO METHOD; POLYMERASE CHAIN REACTION; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; ANTIVIRAL AGENTS; COMPUTER SIMULATION; CONFIDENCE INTERVALS; CYCLOPENTANES; DECISION SUPPORT TECHNIQUES; FEMALE; GUANIDINES; HEALTH CARE COSTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MODELS, ECONOMIC; MODELS, STATISTICAL; MONTE CARLO METHOD; POLYMERASE CHAIN REACTION; QUALITY-ADJUSTED LIFE YEARS; STOCHASTIC PROCESSES; UNITED STATES; YOUNG ADULT;

EID: 79959528501     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Article

References (0)